Medicared For All Logo

Joseph Mclaughlin in Manchester, Connecticut

Home Connecticut Manchester

Joseph Mclaughlin has Hematology/oncology as his primary medical specialty. Their primary office is: 100 Haynes St in Manchester, Connecticut.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 860-646-0670 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2008 (around 16 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Joseph Francis Mclaughlin Office Phone and Directions

Joseph Mclaughlin
Regional Cancer Care Associates Llc
100 Haynes St
Manchester, Connecticut 06040
860-646-0670


Patient Ratings
Please rate your experience with Joseph Mclaughlin below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 860-646-0670


Enter a starting address:


Healthcare Info for Joseph Mclaughlin

Medical School: Sorry, his university is not listed
Graduation Year: 2008
The Primary Medical Specialty for Joseph Mclaughlin is listed as: Hematology/oncology
Approximate Years of Experience: 16
PAC (PECOS ID)#: 7416279856
NPI #: 1013178466
NPI Created On: 06/18/2008
NPI Last Updated Listed as: 03/09/2016
Primary Taxonomy Code: 207RH0000X
License Number:
49687
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Harvard Pilgrim Health Care Inc.
  • Medicare

They are listed as accepting new patients.


Services and Procedures include:

  1. Hydration infusion into a vein
  2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  3. Infusion into a vein for therapy, prevention, or diagnosis
  4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  5. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  7. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  8. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  9. Infusion of chemotherapy into a vein up to 1 hour
  10. Infusion of chemotherapy into a vein
  11. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  12. Irrigation of implanted venous access drug delivery device
  13. New patient office or other outpatient visit, typically 60 minutes
  14. Established patient office or other outpatient visit, typically 5 minutes
  15. Established patient office or other outpatient visit, typically 15 minutes
  16. Established patient office or other outpatient, visit typically 25 minutes
  17. Established patient office or other outpatient, visit typically 40 minutes
  18. Initial hospital inpatient care, typically 70 minutes per day
  19. Subsequent hospital inpatient care, typically 35 minutes per day
  20. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 819746883

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: AKYNZEO

Open Associated Drug #1: 69639-101-01


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 819746885

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: AKYNZEO

Open Associated Drug #1: 69639-101-01


Payments Total: $2,235

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783636925

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $2,235

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783636933

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $2,235

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783636935

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $107

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783636965

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $99

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783636967

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $9

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Travel and Lodging City: Wyomissing

Travel and Lodging State: PA

Travel and Lodging Country: United States

Record ID:: 783636969

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $4,505

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783636979

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $4,505

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783636971

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Hematology/oncology Professionals in Manchester

100 Haynes St
Manchester, CT
Regional Cancer Care Associates Llc

100 Haynes St
Manchester, CT
Regional Cancer Care Associates Llc

100 Haynes St
Manchester, CT
Regional Cancer Care Associates Llc

100 Haynes St
Manchester, CT
Regional Cancer Care Associates Llc

376 Tolland Tpke
Manchester, CT
Hartford Hospital

Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group